Clinical Trial

PALLAS Laser for Skin Diseases

Study acronym: PALLAS-UV
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to get clinical experiences with the PALLAS laser in the treatment of skin conditions that respond well to UV light (vitiligo, psoriasis, alopecia areata, atopic dermatitis). The secondary objective is to assess how user-friendly is the Pallas laser in the treatment of skin diseases. The patient in the trial will receive UVB laser treatment (2 treatments per week for up to 3 months). The treatments will be carried out by the doctors participating in the trial. The treatment takes approximately 10 minutes per session, and can last up to 3 months per patient. Photographic documentation of the lesions to be treated and the lesions treated is taken at the start of the examination and then once a month. At the end of the study, the patient rates the treatment and improvement on a Patient Satisfaction Scale.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-18; most recent amendment 2026-02-05.
Status change: Not Yet Recruiting → Recruiting 2026-02-05
Trial Details
NCT Number NCT07250997
Lead Sponsor Szeged University
Conditions Vitiligo Vulgaris, Psoriasis, Alopecia Areata, Atopic Dermatitis
Enrollment 50 participants
Start Date 2025-12-10
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06